Agios Pharmaceuticals Inc (AGIO) reports a 51% increase in net Pyrukynd revenue and outlines promising future launches and ...

Q4 2024 Management View CEO Brian Goff highlighted the company's strategic focus on expanding the Pyrukynd franchise, with significant growth expected from the potential approval and launch in ...

Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

Sickle cell disease can take a toll on couples, but it's entirely possible to maintain a healthy relationship, says columnist.